about
Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the ...
Read More
2.81
0.01
(0.36%)
4.0M
XNAS Volume
XNAS 24 Dec, 2025 4:30 PM (EST)
Low Financial Strength
Expensive Valuation
Technically Bullish
Momentum Trap
These stocks have weak financials and expensive valuation. Buying interest may quickly dissipate. Investors should exercise caution
View Similar
Embed DVM
Invivyd Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..